ERBB2 and breast carcinoma: Positive phospho-STAT3 (Y705) expression is highest in TNBC, followed by luminal A and luminal B, with HER2-enriched tumors showing the lowest rate of phospho-STAT3 immunostaining [58], suggesting that phospho-STAT3 may be a hallmark of more aggressive breast cancer subtypes.